MedTrace Logo

Study of Topical Ocular PAN-90806 in PDR

NCT02475109 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-09-28

No results posted yet for this study

Summary

The objective of this study is to assess the safety and tolerability of topical ocular PAN-90806 in patients with proliferative diabetic retinopathy.

Conditions

Interventions

DRUG

PAN-90806 Ophthalmic Solution

Sponsors & Collaborators

  • PanOptica, Inc.

    lead INDUSTRY

Principal Investigators

  • Victor H Gonzalez, M.D. · Valley Retina Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-05-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475109 on ClinicalTrials.gov